MARKET

OCGN

OCGN

Ocugen Inc
NASDAQ
1.380
+0.020
+1.47%
After Hours: 1.410 +0.03 +2.17% 19:59 12/15 EST
OPEN
1.420
PREV CLOSE
1.360
HIGH
1.483
LOW
1.370
VOLUME
5.10M
TURNOVER
--
52 WEEK HIGH
1.900
52 WEEK LOW
0.5150
MARKET CAP
431.00M
P/E (TTM)
-6.3653
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at OCGN last week (1208-1212)?
Weekly Report · 1d ago
Ocugen Inc. Stock Rallies 5.7%, Outperforms Market
Dow Jones · 4d ago
Ocugen Showcases Gene Therapy Advances at Oppenheimer Movers in Rare Disease Summit
Reuters · 5d ago
Ocugen CEO to Present at Oppenheimer Movers in Rare Disease Summit
Barchart · 6d ago
Weekly Report: what happened at OCGN last week (1201-1205)?
Weekly Report · 12/08 09:40
Ocugen Inc. Stock Slips 4.8%, Underperforms Market
Dow Jones · 12/01 21:34
Weekly Report: what happened at OCGN last week (1124-1128)?
Weekly Report · 12/01 09:37
Ocugen Inc. Stock Advances 5.1%, Outperforms Market
Dow Jones · 11/28 21:33
More
About OCGN
Ocugen, Inc. is a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines that improve health and offer hope for patients across the globe. Its technology pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, and Inhaled Mucosal Vaccine Platform. It is developing its modifier gene therapy platform, inclusive of OCU400, OCU410, and OCU410ST, for the treatment of multiple inherited retinal diseases, including retinitis pigmentosa, Leber congenital amaurosis, Stargardt disease and multifactorial diseases, such as dry age-related macular degeneration (dAMD) and geographic atrophy. It is developing a next-generation, inhalation-based mucosal vaccine platform based on a novel ChAd vector, which includes OCU500, a COVID-19 vaccine; OCU510, a seasonal quadrivalent flu vaccine, and OCU520, a combination quadrivalent seasonal flu.

Webull offers Ocugen Inc stock information, including NASDAQ: OCGN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OCGN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading OCGN stock methods without spending real money on the virtual paper trading platform.